Testosterone replacement therapy restores testosterone to physiologically normal or slightly supraphysiological levels in men with documented low testosterone (hypogonadism) or age-related decline. The mechanism is direct: exogenous testosterone replaces what the testes are no longer producing adequately. TRT is FDA-approved for diagnosed hypogonadism and has decades of clinical data on efficacy and risk. The primary benefits — improved energy, libido, body composition, mood, and cognitive clarity — are well-documented in hypogonadal men. The primary risks — polycythemia, suppression of natural testosterone production, potential effects on fertility, and cardiovascular considerations in certain populations — are also well-characterized. TRT requires medical supervision, lab monitoring, and ongoing dose management.

Peptides are short chains of amino acids that signal the body to produce more of its own hormones or growth factors, rather than replacing them directly. The most commonly used peptides in longevity and men's health contexts work by stimulating the pituitary to release more growth hormone (GH secretagogues like CJC-1295 and ipamorelin), supporting tissue repair (BPC-157), or modulating inflammation and healing (TB-500). Unlike TRT, most peptides work upstream in the hormonal cascade — they push the body toward its own production rather than substituting external supply. This means they typically have less impact on natural hormone suppression. However, they are also less potent for conditions where deficiency is severe, and the regulatory status of many peptides means they exist in a grayer legal area than TRT.

TRT from a telehealth provider typically costs $75 to $200 per month including medication, labs, and ongoing physician oversight. Budget platforms like TRT Nation and Maximus are at the lower end; premium full-service providers like Defy Medical and Lifeforce are at the higher end. Peptide programs are more variable. Entry-level ipamorelin/CJC-1295 stacks from telehealth providers start around $150 to $250 per month. More complex stacks including BPC-157, TB-500, or research peptides can run $300 to $500 or more. Because peptide prescribing involves compounding pharmacies, pricing is less standardized than TRT.

TRT is clearest for men with documented low testosterone — confirmed by bloodwork showing below-range total testosterone, free testosterone, or both. Symptoms alone are not sufficient for TRT; labs matter. Men with borderline-low or low-normal testosterone who want to improve body composition, recovery, and energy without directly suppressing their own axis may find peptide GH secretagogues a more appropriate first step. Peptides like BPC-157 are not hormone therapy at all — they are most useful for joint and tissue repair, recovery from injury, and gut health, regardless of hormonal status. The two categories serve meaningfully different goals.

Combining TRT with peptide therapy is common in the optimization and men's health space. The most typical stack is TRT plus a GH secretagogue (CJC-1295/ipamorelin) to improve body composition, recovery, and sleep quality. Some protocols also add BPC-157 for joint support and TB-500 for systemic healing. The clinical rationale is that TRT and GH secretagogues target different hormonal pathways and do not meaningfully interfere with each other. Providers like Defy Medical, Lifeforce, and Opt Health offer combined hormone and peptide programs. The key is that adding complexity requires more thorough monitoring — especially labs for IGF-1 levels when using GH-axis peptides alongside TRT.